Jonathan Rios‐Doria

1.3k total citations
22 papers, 943 citations indexed

About

Jonathan Rios‐Doria is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Jonathan Rios‐Doria has authored 22 papers receiving a total of 943 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Oncology and 4 papers in Immunology. Recurrent topics in Jonathan Rios‐Doria's work include DNA Repair Mechanisms (5 papers), Genomics and Chromatin Dynamics (4 papers) and Calpain Protease Function and Regulation (3 papers). Jonathan Rios‐Doria is often cited by papers focused on DNA Repair Mechanisms (5 papers), Genomics and Chromatin Dynamics (4 papers) and Calpain Protease Function and Regulation (3 papers). Jonathan Rios‐Doria collaborates with scholars based in United States, Germany and Japan. Jonathan Rios‐Doria's co-authors include Mark L. Day, Rainer Kuefer, Robert E. Hollingsworth, Raymond Rothstein, Michael G. Rashid, Mark A. Rubin, Ching Ching Leow, Nicholas M. Durham, Leslie Wetzel and Kathleen C. Day and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Jonathan Rios‐Doria

20 papers receiving 926 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jonathan Rios‐Doria United States 13 395 388 264 130 126 22 943
Rafał Sądej Poland 18 339 0.9× 560 1.4× 141 0.5× 190 1.5× 162 1.3× 51 1.2k
Suprit Gupta United States 9 462 1.2× 525 1.4× 402 1.5× 93 0.7× 77 0.6× 13 1.2k
Jean‐Philippe Brosseau Canada 14 304 0.8× 604 1.6× 248 0.9× 50 0.4× 95 0.8× 24 1.2k
Kathleen Spring Canada 10 209 0.5× 347 0.9× 226 0.9× 224 1.7× 22 0.2× 14 846
Kunihiko Kiyono Japan 10 517 1.3× 755 1.9× 129 0.5× 25 0.2× 89 0.7× 12 1.4k
Miwako Kakiuchi Japan 8 413 1.0× 443 1.1× 392 1.5× 83 0.6× 54 0.4× 14 1.1k
Thomas R. Geiger United States 10 422 1.1× 627 1.6× 129 0.5× 66 0.5× 88 0.7× 14 1.0k
Yashira L. Negrón Abril United States 4 204 0.5× 313 0.8× 87 0.3× 50 0.4× 198 1.6× 5 705
Walid Osta United States 8 318 0.8× 855 2.2× 158 0.6× 21 0.2× 313 2.5× 10 1.2k
Heidi A. Neubauer Austria 16 319 0.8× 509 1.3× 217 0.8× 12 0.1× 122 1.0× 23 977

Countries citing papers authored by Jonathan Rios‐Doria

Since Specialization
Citations

This map shows the geographic impact of Jonathan Rios‐Doria's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Rios‐Doria with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Rios‐Doria more than expected).

Fields of papers citing papers by Jonathan Rios‐Doria

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Rios‐Doria. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Rios‐Doria. The network helps show where Jonathan Rios‐Doria may publish in the future.

Co-authorship network of co-authors of Jonathan Rios‐Doria

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan Rios‐Doria. A scholar is included among the top collaborators of Jonathan Rios‐Doria based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan Rios‐Doria. Jonathan Rios‐Doria is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Favata, Margaret, Michaël Weber, K. D. Hammond, et al.. (2025). The FGFR inhibitor pemigatinib overcomes cancer drug resistance to KRAS G12C inhibitors in mesenchymal lung cancer. PLoS ONE. 20(8). e0327588–e0327588.
2.
Rios‐Doria, Jonathan, et al.. (2020). Characterization of human cancer xenografts in humanized mice. Journal for ImmunoTherapy of Cancer. 8(1). e000416–e000416. 45 indexed citations
3.
Tyagi, Puneet, Sergei Pechenov, Jonathan Rios‐Doria, et al.. (2018). Evaluation of Pyrrolobenzodiazepine-Loaded Nanoparticles: A Targeted Drug Delivery Approach. Journal of Pharmaceutical Sciences. 108(4). 1590–1597. 2 indexed citations
4.
Rios‐Doria, Jonathan, Jay Harper, Raymond Rothstein, et al.. (2017). Antibody–Drug Conjugates Bearing Pyrrolobenzodiazepine or Tubulysin Payloads Are Immunomodulatory and Synergize with Multiple Immunotherapies. Cancer Research. 77(10). 2686–2698. 91 indexed citations
5.
6.
Dosch, Joseph S., Shanshan Wan, Kathryn E. Luker, et al.. (2017). Targeting ADAM17 inhibits human colorectal adenocarcinoma progression and tumor-initiating cell frequency. Oncotarget. 8(39). 65090–65099. 36 indexed citations
7.
Rios‐Doria, Jonathan, Jay Harper, Raymond Rothstein, et al.. (2017). Abstract 4596: Antibody-drug conjugates bearing pyrrolobenzodiazepine or tubulysin payloads alter the tumor immune microenvironment and synergize with multiple immunotherapies. Cancer Research. 77(13_Supplement). 4596–4596. 1 indexed citations
8.
Gilbreth, Ryan, Leslie Wetzel, Horacio Cabral, et al.. (2016). Lipid- and polyion complex-based micelles as agonist platforms for TNFR superfamily receptors. Journal of Controlled Release. 234. 104–114. 15 indexed citations
9.
Hay, Carl, Erin Sult, Qihui Huang, et al.. (2016). Targeting CD73 in the tumor microenvironment with MEDI9447. OncoImmunology. 5(8). e1208875–e1208875. 229 indexed citations
10.
Rios‐Doria, Jonathan, Nicholas M. Durham, Leslie Wetzel, et al.. (2015). Doxil Synergizes with Cancer Immunotherapies to Enhance Antitumor Responses in Syngeneic Mouse Models. Neoplasia. 17(8). 661–670. 146 indexed citations
11.
Rios‐Doria, Jonathan, et al.. (2010). Three-color intranuclear staining for measuring mitosis and apoptosis in cells transfected with a GFP-tagged histone. Biotechnic & Histochemistry. 85(2). 127–131. 1 indexed citations
12.
Rios‐Doria, Jonathan, Jorge Meléndez-Zajgla, & Álvaro N.A. Monteiro. (2009). Three-color intranuclear staining for measuring mitosis and apoptosis in cells transfected with a GFP-tagged histone. Biotechnic & Histochemistry. 85(2). 1–5. 1 indexed citations
13.
Rios‐Doria, Jonathan, et al.. (2009). Ectopic expression of Histone H2AX mutants reveal a role for its post-translational modifications. Cancer Biology & Therapy. 8(5). 422–434. 14 indexed citations
14.
Rios‐Doria, Jonathan, et al.. (2006). A role for histone H2AX in cell cycle control and apoptosis.. Cancer Research. 66. 1184–1184. 1 indexed citations
15.
Rios‐Doria, Jonathan, et al.. (2006). DNA damage response: Determining the fate of phosphorylated histone H2AX. Cancer Biology & Therapy. 5(2). 142–144. 12 indexed citations
16.
Rios‐Doria, Jonathan & Mark L. Day. (2004). Truncated E‐cadherin potentiates cell death in prostate epithelial cells. The Prostate. 63(3). 259–268. 18 indexed citations
17.
Kuefer, Rainer, et al.. (2004). 410: Cleavage of E-Cadherin and the Role of an 80KDa Fragment in the Metastatic Progression of Prostate Cancer. The Journal of Urology. 171(4S). 108–108. 1 indexed citations
18.
Rios‐Doria, Jonathan, Rainer Kuefer, Stephen P. Ethier, & Mark L. Day. (2004). Cleavage of β-Catenin by Calpain in Prostate and Mammary Tumor Cells. Cancer Research. 64(20). 7237–7240. 64 indexed citations
19.
Rios‐Doria, Jonathan, Kathleen C. Day, Rainer Kuefer, et al.. (2003). The Role of Calpain in the Proteolytic Cleavage of E-cadherin in Prostate and Mammary Epithelial Cells. Journal of Biological Chemistry. 278(2). 1372–1379. 148 indexed citations
20.
Rashid, Michael G., Martin G. Sanda, Christopher J. Vallorosi, et al.. (2001). Posttranslational truncation and inactivation of human E-cadherin distinguishes prostate cancer from matched normal prostate.. PubMed. 61(2). 489–92. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rafał Sądej Breakdown of academic impact, for papers by Suprit Gupta Breakdown of academic impact, for papers by Jean‐Philippe Brosseau Breakdown of academic impact, for papers by Kathleen Spring Breakdown of academic impact, for papers by Kunihiko Kiyono Breakdown of academic impact, for papers by Miwako Kakiuchi Breakdown of academic impact, for papers by Thomas R. Geiger Breakdown of academic impact, for papers by Yashira L. Negrón Abril Breakdown of academic impact, for papers by Walid Osta Breakdown of academic impact, for papers by Heidi A. Neubauer
Rankless by CCL
2026